Rendering

Component: (Network and Table)
Network
00400 - Statement - Consolidated Statements Of Cash Flows
(http://www.acadiahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Consolidated Statements Of Cash Flows [Abstract]Period [Axis]
2011-01-01 - 2011-12-31
2010-01-01 - 2010-12-31
2009-01-01 - 2009-12-31
Consolidated Statements Of Cash Flows [Abstract]
 
 
 
Operating activities:
 
 
 
Net (loss) income
(34,892,000) 
6,210,000  
2,877,000  
Adjustments to reconcile net (loss) income to net cash provided by continuing operating activities:
 
 
 
Depreciation and amortization
4,288,000  
976,000  
997,000  
Provision for bad debts
3,226,000  
2,239,000  
2,424,000  
Amortization of debt issuance costs
1,271,000  
 
 
Equity-based compensation expense
17,320,000  
 
 
Deferred income tax expense
(6,442,000) 
(145,000) 
 
Other
(168,000) 
 
 
Loss (income) from discontinued operations, net of taxes
2,019,000  
471,000  
(119,000) 
Change in operating assets and liabilities, net of effect of acquisitions:
 
 
 
Accounts receivable
(5,051,000) 
(2,174,000) 
(2,994,000) 
Other current assets
(1,635,000) 
35,000  
(1,215,000) 
Other assets
(969,000) 
 
 
Accounts payable and other accrued liabilities
3,346,000  
541,000  
2,066,000  
Accrued salaries and benefits
(1,654,000) 
187,000  
1,369,000  
Other liabilities
734,000  
(250,000) 
644,000  
Net cash (used in) provided by continuing operating activities
(18,607,000) 
 
8,090,000  
 
6,049,000  
 
Net cash (used in) provided by discontinued operating activities
(2,059,000) 
105,000  
119,000  
Net cash (used in) provided by operating activities
(20,666,000) 
 
8,195,000  
 
6,168,000  
 
Investing activities:
 
 
 
Cash paid for acquisitions, net of cash acquired
(206,379,000) 
 
(3,142,000) 
Cash paid for capital expenditures
(9,558,000) 
(1,495,000) 
(334,000) 
Cash paid for real estate acquisitions
(8,706,000) 
 
 
Other
(689,000) 
 
 
Net cash used in continuing investing activities
(225,332,000) 
 
(1,495,000) 
 
(3,476,000) 
 
Net cash (used in) provided by discontinued investing activities
(238,000) 
(3,000) 
65,000  
Net cash used in investing activities
(225,570,000) 
 
(1,498,000) 
 
(3,411,000) 
 
Financing activities:
 
 
 
Borrowings on long-term debt
282,485,000  
 
 
Principal payments on long-term debt
(5,063,000) 
(275,000) 
(813,000) 
Repayment of long-term debt
(9,984,000) 
 
 
Payment of debt issuance costs
(12,111,000) 
 
 
Proceeds from stock option exercises
38,000  
 
 
Proceeds from issuance of common stock
68,059,000  
 
 
Payment of equity issuance costs
(897,000) 
 
 
Cash distribution paid to equity holders
(74,441,000) 
 
 
Contribution from Holdings
51,029,000  
 
2,500,000  
Distributions to equity holders
(375,000) 
(2,297,000) 
 
Net cash provided by (used in) financing activities
298,740,000  
 
(2,572,000) 
 
1,687,000  
 
Net increase in cash and cash equivalents
52,504,000  
 
4,125,000  
 
4,444,000  
 
Cash and cash equivalents at beginning of the period
8,614,000  
4,489,000  
45,000  
Cash and cash equivalents at end of the period
61,118,000  
 
8,614,000  
 
4,489,000  
 
Supplemental Cash Flow Information:
 
 
 
Cash paid for interest
5,053,000  
587,000  
534,000  
Cash paid for income taxes
2,564,000  
700,000  
30,000  
Significant Non-Cash Transactions:
 
 
 
Issuance of common stock in connection with acquisition
44,025,000  
 
 
Issuance of replacement share-based awards in connection with acquisition
1,027,000  
 
 
Effect of acquisitions:
 
 
 
Assets acquired, excluding cash
278,895,000  
 
3,142,000  
Liabilities assumed
(27,464,000) 
 
 
Issuance of common stock in connection with acquisition
(44,025,000) 
 
 
Issuance of replacement share-based awards in connection with acquisition
(1,027,000) 
 
 
Cash paid for acquisitions, net of cash acquired
206,379,000  
 
3,142,000